Stalicla Secures $17.4 Million in Series B Financing to Propel Precision Neuro Advancements
Amount Raised
$17.4 Million
Round Type
Series B
GenevaBiotechnologyInvestors
Description
Stalicla SA announces the successful completion of the first closing of its Series B financing round, securing $17.4 million led by SPRIM Global Investments Pte, Ltd, with key participation from core investors, including a $3.8 million credit facility. The proceeds will be utilized for pioneering precision Autism Spectrum Disorder (ASD) Phase 2 trial – STP1, the establishment of its STP7 mGluR5 Negative Allosteric Modulator (mGluR5 NAM) platform, and the ongoing biosampling/patient identification trial STA-B-001.
Quick answer
Stalicla raised $17.4 Million in a Series B round, dated January 17, 2024. Investors: Core Investors and Sprim Global Investments Pte, Ltd. Stalicla is based in Geneva, Geneva, Switzerland.
- How much did Stalicla raise?
- Stalicla raised $17.4 Million in a Series B round on January 17, 2024.
- Who invested in Stalicla?
- Core Investors and Sprim Global Investments Pte, Ltd are named as investors in this round.
- What does Stalicla do?
- STALICLA SA is a Swiss clinical-stage biopharmaceutical company, pioneering precision treatment in neurodevelopmental and neuropsychiatric disorders.
- Where is Stalicla based and how big is it?
- Stalicla is based in Geneva, Geneva, Switzerland. Fundz records about 26 employees.
- Who are the decision-makers at Stalicla?
- Fundz holds 1 contact at Stalicla. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Stalicla that raised within 45 days of this round, from Fundz verified event records.
- Crinetics Pharmaceuticals raised $350M on March 1, 2024.
- GreenLab raised $1.6M (Seed) on March 1, 2024.
- Myomar Molecular raised $1.1M (Pre-Seed) on March 1, 2024.
- Parabilis Medicines raised $145M (Series E) on March 1, 2024.
- Tempo Therapeutics raised $16M on March 1, 2024.
- TwoStep Therapeutics raised $6.5M on March 1, 2024.
Who to call at Stalicla, and when
A new round usually means Stalicla is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Stalicla raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Stalicla, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Stalicla. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Stalicla raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansStalicla raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.